Cargando…

Mild cognitive decline in type 2 diabetes mellitus patients – risk factors and pathogenesis: role of DPP4 activity and future possible therapeutic targets

Detalles Bibliográficos
Autores principales:	Gul, Owais, Gul, Saqib
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366363/ https://www.ncbi.nlm.nih.gov/pubmed/30787614 http://dx.doi.org/10.2147/NDT.S200663

Ejemplares similares

Posterior pituitary neurohormonal disturbances in schizophrenia and role of oxytocin in treatment – need for more short- and long-term studies
por: Gul, Owais, et al.
Publicado: (2018)

Potential contribution of diabetes mellitus to orthostatic blood pressure fall and conversion of mild cognitive impairment to dementia
por: Muratli, Sevilay, et al.
Publicado: (2016)

COVID-19 and diabetes: Is this association driven by the DPP4 receptor? Potential clinical and therapeutic implications
por: Barchetta, Ilaria, et al.
Publicado: (2020)

Diabetes and cognitive decline: Challenges and future direction
por: Ab-Hamid, Norhamidar, et al.
Publicado: (2023)

Glucagon-Like Peptide-1, Diabetes, and Cognitive Decline: Possible Pathophysiological Links and Therapeutic Opportunities
por: Mossello, Enrico, et al.
Publicado: (2011)

Recurrent Pleural Effusions Secondary to Pancreaticopleural Fistula: A Case Presentation
por: Shaikh, Ali Tariq, et al.
Publicado: (2023)

Mild Behavioral Impairment and Subjective Cognitive Decline Predict Cognitive and Functional Decline
por: Ismail, Zahinoor, et al.
Publicado: (2021)

Phytochemicals in Garlic Extract Inhibit Therapeutic Enzyme DPP-4 and Induce Skeletal Muscle Cell Proliferation: A Possible Mechanism of Action to Benefit the Treatment of Diabetes Mellitus
por: Kalhotra, Poonam, et al.
Publicado: (2020)

Therapeutic goal of diabetes mellitus
por: Wiwanitkit, Somsri, et al.
Publicado: (2011)

DPP4 in Diabetes
por: Röhrborn, Diana, et al.
Publicado: (2015)

DPP-4 Inhibitors Improve Liver Dysfunction in Type 2 Diabetes Mellitus
por: Kanazawa, Ippei, et al.
Publicado: (2014)

Sleep and future cognitive decline
por: Coulthard, Elizabeth, et al.
Publicado: (2021)

Future Discounting in Congo Basin Hunter-Gatherers Declines with Socio-Economic Transitions
por: Salali, Gul Deniz, et al.
Publicado: (2015)

Diabetes Mellitus, Edentulism, and Trajectory of Cognitive Decline Among Older Adults
por: Wu, Bei, et al.
Publicado: (2021)

Diagnostic, Prognostic, and Mechanistic Biomarkers of Diabetes Mellitus-Associated Cognitive Decline
por: Ehtewish, Hanan, et al.
Publicado: (2022)

The effect of statins on rate of cognitive decline in mild cognitive impairment
por: Smith, Kyle B., et al.
Publicado: (2017)

Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline
por: Eliassen, Carl F., et al.
Publicado: (2017)

DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
por: Valencia, Inés, et al.
Publicado: (2020)

Targeted therapeutic mild hypercapnia after cardiac arrest
por: Eastwood, Glenn M., et al.
Publicado: (2017)

The Pathogenesis of Diabetes Mellitus
por: Lukens, F. D. W.
Publicado: (1944)

Saxagliptin: A Selective DPP-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus
por: Shubrook, Jay, et al.
Publicado: (2011)

Association of DPP4 Gene Polymorphisms with Type 2 Diabetes Mellitus in Malaysian Subjects
por: Ahmed, Radwan H., et al.
Publicado: (2016)

Influence of nutritional intervention on children with type 1 diabetes mellitus and DPP-4 in serum
por: Dong, Yan-Jun, et al.
Publicado: (2017)

DPP4 Gene Polymorphism Associates With Type 2 Diabetes Mellitus in Older Adults
por: Alves, Elisa, et al.
Publicado: (2020)

Capturing Subjective Mild Cognitive Decline in Parkinson’s Disease
por: Rosenblum, Sara, et al.
Publicado: (2022)

Disproportionate Decline of Executive Functions in Early Mild Cognitive Impairment, Late Mild Cognitive Impairment, and Mild Alzheimer's Disease
por: Kim, Sangsoon, et al.
Publicado: (2016)

Patterns of Cognitive Decline Prior to Dementia in Persons with Mild Cognitive Impairment
por: Cloutier, Simon, et al.
Publicado: (2015)

Microstructural brain changes track cognitive decline in mild cognitive impairment
por: Reas, Emilie T., et al.
Publicado: (2018)

Trajectories of subjective cognitive decline, and the risk of mild cognitive impairment and dementia
por: Liew, Tau Ming
Publicado: (2020)

Neuropsychiatric Profile as a Predictor of Cognitive Decline in Mild Cognitive Impairment
por: Roberto, Natalia, et al.
Publicado: (2021)

Plasma biomarkers for prognosis of cognitive decline in patients with mild cognitive impairment
por: Kivisäkk, Pia, et al.
Publicado: (2022)

Biomarkers for cognitive decline in patients with diabetes mellitus: evidence from clinical studies
por: Zhao, Xue, et al.
Publicado: (2017)

DPP8 is a novel therapeutic target for multiple myeloma
por: Sato, Tsutomu, et al.
Publicado: (2019)

DPP3: From biomarker to therapeutic target of cardiovascular diseases
por: Ye, Peng, et al.
Publicado: (2022)

Letter: The Effect of DPP-4 Inhibitors on Metabolic Parameters in Patients with Type 2 Diabetes (Diabetes Metab J 2014;38:211-9)
por: Lee, Seung-Hwan
Publicado: (2014)

Subjective cognitive decline as a predictor of future cognitive decline: a systematic review
por: Parfenov, Vladimir Anatolevich, et al.
Publicado: (2020)

SMS reminders- future in self-care management of diabetes mellitus?
por: Riaz, Talha, et al.
Publicado: (2012)

Medicinal Chemistry and Applications of Incretins and DPP-4 Inhibitors in the Treatment of Type 2 Diabetes Mellitus
por: Lotfy, Mohamed, et al.
Publicado: (2011)

The Dipeptidyl Peptidase (DPP)-4 Inhibitors for Type 2 Diabetes Mellitus in Challenging Patient Groups
por: Kountz, David
Publicado: (2013)

Use of DPP-4 inhibitors in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bv5bcrg6rlcqdpcdmkdssfv3m7